Scarica l'app Stockscreener
7.40
19.16%
1.19
Precedente Chiudi:
$6.21
Aprire:
$6.5
Volume 24 ore:
57,243
Relative Volume:
1.56
Capitalizzazione di mercato:
$13.35M
Reddito:
$63,000
Utile/perdita netta:
$-47.73M
Rapporto P/E:
-0.5139
EPS:
-14.3996
Flusso di cassa netto:
$-13.18M
1 W Prestazione:
+24.16%
1M Prestazione:
-17.78%
6M Prestazione:
-23.71%
1 anno Prestazione:
-59.65%
Intervallo 1D:
$6.50
$7.40
Intervallo di 1 settimana:
$5.8269
$7.50
Portata 52W:
$4.9101
$28.75
Gt Biopharma Inc Stock (GTBP) Company Profile
Nome
Gt Biopharma Inc
Settore
Industria
Telefono
(800) 304-9888
Indirizzo
505 MONTGOMERY STREET, SAN FRANCISCO
Compare GTBP vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GTBP
Gt Biopharma Inc
|
7.40 | 13.35M | 63,000 | -47.73M | -13.18M | -14.40 |
VRTX
Vertex Pharmaceuticals Inc
|
508.74 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.35 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.50 | 53.23B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.30 | 42.34B | 5.76B | 514.49M | 1.10B | 4.4813 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Iniziato | ROTH MKM | Buy |
| 2021-05-24 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-13 | Iniziato | B. Riley Securities | Buy |
| 2021-03-17 | Iniziato | ROTH Capital | Buy |
Gt Biopharma Inc Borsa (GTBP) Ultime notizie
Form S-1 GT Biopharma Inc For: 9 October By Investing.com - Investing.com Canada
Gt Biopharma Selling Stockholders To Offer Up To 13,502,835 Shares Of Common Stock - TradingView
TRex Bio Files for Nasdaq IPO - Yahoo! Finance Canada
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo! Finance Canada
GT Biopharma regains Nasdaq compliance: what it means for GT Biopharma stock - AD HOC NEWS
GT Biopharma sells USD 7.75 million: what it means for GT Biopharma stock - AD HOC NEWS
With $31.2M left to sell, GT Biopharma (GTBP) has made its first equity sale. - stocktitan.net
BioHarvest Sciences launches buyback of up to 5% of shares - Yahoo! Finance Canada
GT Biopharma Regains Nasdaq Minimum Bid Compliance - The Globe and Mail
GT Biopharma Regains Nasdaq Minimum Bid Compliance - The Globe and Mail
GT Biopharma regains Nasdaq $1.00 minimum bid compliance after 10-day stretch - TradingView
GT Biopharma Expands Series M Preferred Financing Agreement - The Globe and Mail
GT Biopharma Upsizes Preferred Stock Offering to US$7.75 Million With New Investor - minichart.com.sg
GT Biopharma Increases Series M Preferred Stock Private Placement with New Investor - Kalkine Media
GT Biopharma Expands Private Placement to $8.61M Stated Value, Adds Greenshoe Up to $34.7M - TradingView
GT Biopharma (Nasdaq:GTBP)Stock Analysis - Simply Wall Street
New investor hits 9.99% ceiling in GT Biopharma (GTBP) - Stock Titan
GT Biopharma announces $7.45 million private placement of preferred stock and warrants - Investing.com Nigeria
Form 8K GT Biopharma Inc For: 15 September By Investing.com - Investing.com Nigeria
Form 8K GT Biopharma Inc For: 15 September By Investing.com - Investing.com UK
GT Biopharma announces $7.45 million private placement of preferred stock and warrants - Investing.com UK
Form 8K GT Biopharma Inc For: 15 September By Investing.com - Investing.com South Africa
Why Has GT Biopharma (GTBP) Become a Talking Point? - Kalkine Media
GT Biopharma, Inc. announced that it expects to receive $30 million in funding - marketscreener.com
Why Has GT Biopharma (GTBP) Become a Talking Point? - kalkinemedia.com
GTBP: Phase I TriKE trials show early promise, with key data expected soon and broad expansion potential - TradingView
Price to sales ratio of GT Biopharma Inc – MUN:OXI - tradingview.com
EBITDA per share of GT Biopharma Inc – MUN:OXI - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
GTBP Price Today: GT Biopharma Inc. Stock Price, Quote & Chart | MEXC - MEXC
GT Biopharma Pops Ahead of Presentation - Baystreet.ca
GT Biopharma Pops Ahead of Presentation - Baystreet.ca
GT Biopharma Pops Ahead of Presentation - Baystreet.ca
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026 - marketscreener.com
A live briefing will cover a platform designed to help immune cells kill cancer - Stock Titan
EBITDA per share of GT Biopharma Inc – FWB:OXI - TradingView
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
symbol__ Stock Quote Price and Forecast - CNN
GT Biopharma (GTBP) Slides 10.95% to $0.25 as Bearish Momentum BuildsSuperTrend - siam.in
GT Biopharma (GTBP) Slides 10.95% to $0.25 as Bearish Momentum BuildsFactor Rotation - vinanet.vn
GT Biopharma Implements Reverse Stock Split, Streamlines Capital Structure - TipRanks
GT Biopharma (GTBP) Slides 10.95% to $0.25 as Bearish Momentum BuildsInitial Balance - dars.gov.et
GTBP stock holds steady as GT Biopharma advances TriKE cancer pipeline - ad-hoc-news.de
Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes - Eastern Progress
Stock Quotes, Business News and Data from Stock Markets | MSN Money - MSN
GTBP Q1 2026 Earnings: EPS Misses Estimates as Stock Drops 3.72%Dividend Cut Risk - vinanet.vn
GT Biopharma Shareholders Approve Reverse Split and Incentive Plan - TipRanks
GT Biopharma (NASDAQ: GTBP) wins approval for reverse split and share plan changes - Stock Titan
GT Biopharma Q2 Results: Net Loss Falls To $4.5 Million - scanx.trade
Gt Biopharma Reports Second Quarter 2026 Financial Results - TradingView
Gt Biopharma Inc Azioni (GTBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):